IGF-1

LUND, Sweden, July 17, 2026 Camurus announced that the U.S. Food and Drug Administration (FDA) has accepted for review...

SOUTH SAN FRANCISCO, Calif., May 26, 2026 Marea Therapeutics announced that new data from its first-in-human Phase 1 clinical...